Cureus Announces Winners of Case Report Publishing Competition Aimed at Advancing MR-Guided Radiation Therapy

Tuesday, May 15, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

Resulting 24 Peer Reviewed Papers on MR-Guided Radiotherapy Increasing Access to Clinical Information to Help Improve Treatment of Cancer

SAN FRANCISCO, May 15, 2018 /PRNewswire/ -- The Cureus Journal of Medical Science announced today the winners of a medical

case report publishing competition aimed at advancing the clinical practice of MR-guided radiation therapy. The competition documented clinical applications and experience with this novel form of cancer treatment, making the information freely available to the oncology community.

MR-guided radiation therapy represents a fundamental change in the way radiation dose is planned, guided, and delivered. Leveraging the ability to quickly perform daily on-table MR-guided plan adaptations, while also providing automated, real-time soft-tissue tracking and gating, a new frontier of precision radiation medicine is rapidly emerging.

Of the 24 case reports and case series entered into the competition, the three winning papers, as selected using a crowdsourced score measuring the study's quality, presentation and importance, were:

  • 1st Place: "MRI-guided Dose-escalated Salvage Radiotherapy for Bulky Bladder Neck Recurrence of Prostate Cancer" – Kishan et al., University of California, Los Angeles
  • 2nd Place: "A Case Report of Salvage Radiotherapy for a Patient with Recurrent Gastric Cancer and Multiple Comorbidities Using Real-time MRI-guided Adaptive Treatment System" – Chun et al., Seoul National University Hospital
  • 3rd Place: Magnetic Resonance Imaging Guidance Mitigates the Effects of Intrafraction Prostate Motion During Stereotactic Body Radiotherapy for Prostate Cancer – Hedge, et. al., University of California, Los Angeles

"We're honored that our paper highlighting the benefits of MR-guided radiation therapy for recurrent prostate cancer was ranked highest by our peers and are proud to share these and other highlights from our more than 3 years of clinical experience with MR-guided radiation therapy with the radiation oncology community via Cureus," said Michael L. Steinberg, M.D., Professor and Chair of the Dept. of Radiation Oncology at the David Geffen School of Medicine at UCLA. "We've seen first-hand how MR-guided radiation therapy has changed the way we treat cancer and hope our research encourages other institutions to expand their clinical practice and the applications treatable with radiation."

"MR-guided radiation therapy is a field of great interest within the oncology community and we're pleased to provide a peer-reviewed forum that's free and Open Access to ensure the valuable research taking place gets into the hands of those in the trenches treating patients every day around the world," said John R. Adler, M.D., CEO of Cureus and Professor of Neurosurgery at Stanford University. "I want to thank all the authors who submitted their impressive case reports to this publishing competition and to congratulate the researchers from UCLA and Seoul National University Hospital on their award-winning work."

All articles published in the Cureus Journal of Medical Science, a peer-reviewed online medical journal that provides free and Open Access to medical research and clinical discoveries, are also indexed in PubMed Central to encourage dissemination and foster educational awareness.

About the MR-Guided Radiation Therapy Case Report Publishing CompetitionAuthors were invited to contribute their MR-guided radiotherapy case reports and case series to the competition for publication in the Cureus Journal of Medical Science.

All eligible submissions underwent an independent pre-publication peer review conducted by a world-class team of radiation oncology and medical physics experts.

Winners were selected by clinicians and researchers using a crowdsourced score that measures the study's quality, presentation and importance – a post-publication peer-review feature unique to Cureus. This rating, called Scholarly Impact Quotient (SIQ), allows clinicians and researchers to quickly assess and rank article quality in a manner similar to that of Amazon® and Yelp® community reviews.

Three monetary prizes were awarded to the published articles that received the highest Cureus SIQ ratings at the deadline of the scoring period: $3,000 USD for first place, $2,000 USD for second place and $1,000 USD for third place.

Program administration was made possible through the financial support of ViewRay (Nasdaq: VRAY), one of the manufacturers of MR-guided radiation therapy systems. Article selection, editorial review, peer review, publication, and competition winner determination are strictly independent of the sponsor.

To learn more, please visit

About CureusThe Cureus Journal of Medical Science is an Open Access, peer-reviewed online medical publishing platform that leverages a unique crowdsourced, post-publication review process. Relying on the collective intelligence of its clinical community, Cureus enables faster and low cost or free publication, greater access, and ultimately, better research. Visit for more information.

Media Contact: Henrik Bacho                                                                            Chief Marketing Officer,


Cision View original content:

SOURCE Cureus Journal of Medical Science

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store